13,897 Shares in Colgate-Palmolive Company $CL Purchased by Arjuna Capital

Arjuna Capital acquired a new stake in shares of Colgate-Palmolive Company (NYSE:CL) in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 13,897 shares of the company’s stock, valued at approximately $1,184,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. HighPoint Advisor Group LLC raised its holdings in shares of Colgate-Palmolive by 0.7% during the fourth quarter. HighPoint Advisor Group LLC now owns 15,877 shares of the company’s stock valued at $1,255,000 after acquiring an additional 109 shares during the period. Clear Harbor Asset Management LLC grew its position in Colgate-Palmolive by 2.6% during the 4th quarter. Clear Harbor Asset Management LLC now owns 4,503 shares of the company’s stock worth $356,000 after purchasing an additional 113 shares in the last quarter. Moneta Group Investment Advisors LLC lifted its holdings in shares of Colgate-Palmolive by 0.7% in the fourth quarter. Moneta Group Investment Advisors LLC now owns 15,506 shares of the company’s stock valued at $1,225,000 after purchasing an additional 114 shares in the last quarter. Sunpointe LLC boosted its position in shares of Colgate-Palmolive by 4.0% in the fourth quarter. Sunpointe LLC now owns 3,056 shares of the company’s stock worth $241,000 after buying an additional 117 shares during the period. Finally, ANB Bank grew its holdings in shares of Colgate-Palmolive by 1.7% during the first quarter. ANB Bank now owns 7,200 shares of the company’s stock valued at $614,000 after buying an additional 120 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Performance

Shares of CL stock opened at $92.84 on Friday. Colgate-Palmolive Company has a fifty-two week low of $74.54 and a fifty-two week high of $99.33. The stock’s 50-day moving average is $90.46 and its two-hundred day moving average is $88.54. The company has a debt-to-equity ratio of 16.33, a current ratio of 1.02 and a quick ratio of 0.67. The firm has a market cap of $74.29 billion, a P/E ratio of 36.12, a PEG ratio of 4.90 and a beta of 0.33.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, May 1st. The company reported $0.97 EPS for the quarter, beating the consensus estimate of $0.94 by $0.03. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.The business had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.22 billion. During the same quarter in the previous year, the business posted $0.91 EPS. The firm’s quarterly revenue was up 8.4% compared to the same quarter last year. Analysts predict that Colgate-Palmolive Company will post 3.81 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Monday, July 20th will be paid a dividend of $0.53 per share. The ex-dividend date is Monday, July 20th. This represents a $2.12 annualized dividend and a dividend yield of 2.3%. Colgate-Palmolive’s dividend payout ratio is 82.49%.

Analyst Ratings Changes

Several brokerages recently issued reports on CL. UBS Group increased their price objective on Colgate-Palmolive from $100.00 to $106.00 and gave the stock a “buy” rating in a research note on Thursday. Wells Fargo & Company lifted their target price on Colgate-Palmolive from $92.00 to $95.00 and gave the company an “equal weight” rating in a research note on Wednesday, July 8th. Morgan Stanley reiterated an “overweight” rating on shares of Colgate-Palmolive in a report on Monday, May 4th. Bank of America decreased their price target on shares of Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating for the company in a report on Friday, April 10th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $99.00 price objective on shares of Colgate-Palmolive in a research report on Monday, May 4th. Twelve research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $97.41.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.